141 related articles for article (PubMed ID: 14691675)
1. Usefulness of graphical invariants in quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.
Bagchi MC; Maiti BC; Mills D; Basak SC
J Mol Model; 2004 Apr; 10(2):102-11. PubMed ID: 14691675
[TBL] [Abstract][Full Text] [Related]
2. Application of quantitative structure-activity relationships to the modeling of antitubercular compounds. 1. The hydrazide family.
Ventura C; Martins F
J Med Chem; 2008 Feb; 51(3):612-24. PubMed ID: 18176999
[TBL] [Abstract][Full Text] [Related]
3. Mode of action and quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.
Seydel JK; Schaper KJ; Wempe E; Cordes HP
J Med Chem; 1976 Apr; 19(4):483-92. PubMed ID: 817022
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationship (QSAR) studies of quinolone antibacterials against M. fortuitum and M. smegmatis using theoretical molecular descriptors.
Bagchi MC; Mills D; Basak SC
J Mol Model; 2007 Jan; 13(1):111-20. PubMed ID: 16932890
[TBL] [Abstract][Full Text] [Related]
5. Rational design of new antituberculosis agents: receptor-independent four-dimensional quantitative structure-activity relationship analysis of a set of isoniazid derivatives.
Pasqualoto KF; Ferreira EI; Santos-Filho OA; Hopfinger AJ
J Med Chem; 2004 Jul; 47(15):3755-64. PubMed ID: 15239654
[TBL] [Abstract][Full Text] [Related]
6. Fragment-based and classical quantitative structure-activity relationships for a series of hydrazides as antituberculosis agents.
Andrade CH; Salum Lde B; Castilho MS; Pasqualoto KF; Ferreira EI; Andricopulo AD
Mol Divers; 2008 Feb; 12(1):47-59. PubMed ID: 18373208
[TBL] [Abstract][Full Text] [Related]
7. Isoniazid is not a lead compound for its pyridyl ring derivatives, isonicotinoyl amides, hydrazides, and hydrazones: a critical review.
Scior T; Garcés-Eisele SJ
Curr Med Chem; 2006; 13(18):2205-19. PubMed ID: 16918349
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
Ventura C; Latino DA; Martins F
Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
[TBL] [Abstract][Full Text] [Related]
9. Isonicotinoylhydrazone analogs of isoniazid: relationship between superoxide scavenging and tuberculostatic activities.
Georgieva N; Gadjeva V
Biochemistry (Mosc); 2002 May; 67(5):588-91. PubMed ID: 12059780
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, antimycobacterial, antiviral, antimicrobial activity and QSAR studies of N(2)-acyl isonicotinic acid hydrazide derivatives.
Judge V; Narasimhan B; Ahuja M; Sriram D; Yogeeswari P; De Clercq E; Pannecouque C; Balzarini J
Med Chem; 2013 Feb; 9(1):53-76. PubMed ID: 22762163
[TBL] [Abstract][Full Text] [Related]
12. Virtual generation of agents against Mycobacterium tuberculosis. A QSAR study.
Besalú E; Ponec R; de Julián-Ortiz JV
Mol Divers; 2003; 6(2):107-20. PubMed ID: 14761161
[TBL] [Abstract][Full Text] [Related]
13. Four hydrazide compounds that inhibit the growth of mycobacterium tuberculosis.
Bartzatt R; Cirillo SL; Cirillo JD
Physiol Chem Phys Med NMR; 2008; 40():55-65. PubMed ID: 20070040
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
Nayyar A; Monga V; Malde A; Coutinho E; Jain R
Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
[TBL] [Abstract][Full Text] [Related]
15. In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: part 14.
Maccari R; Ottanà R; Vigorita MG
Bioorg Med Chem Lett; 2005 May; 15(10):2509-13. PubMed ID: 15863306
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships on purine and 2,3-dihydropurine derivatives as antitubercular agents: a data mining approach.
Pietra D; Imbriani M; Borghini A; Giorgi I; Settimo FD; Breschi MC; Campa M; Batoni G; Brancatisano FL; Bianucci AM
Chem Biol Drug Des; 2011 Oct; 78(4):718-24. PubMed ID: 21756283
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic investigation of the oxidation of hydrazides: implications for the activation of the TB drug isoniazid.
Amos RI; Gourlay BS; Yates BF; Schiesser CH; Lewis TW; Smith JA
Org Biomol Chem; 2013 Jan; 11(1):170-6. PubMed ID: 23165368
[TBL] [Abstract][Full Text] [Related]
19. Lower cytotoxicity, high stability, and long-term antibacterial activity of a poly(methacrylic acid)/isoniazid/rifampin nanogel against multidrug-resistant intestinal Mycobacterium tuberculosis.
Chen T; Li Q; Guo L; Yu L; Li Z; Guo H; Li H; Zhao M; Chen L; Chen X; Zhong Q; Zhou L; Wu T
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():659-65. PubMed ID: 26478357
[TBL] [Abstract][Full Text] [Related]
20. On an aspect of calculated molecular descriptors in QSAR studies of quinolone antibacterials.
Ghosh P; Thanadath M; Bagchi MC
Mol Divers; 2006 Aug; 10(3):415-27. PubMed ID: 16896544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
